Sorry, the video which you have requested is not yet processed.

Filter By:
06:04
Lymphoma expert Dr. Dan Greenwald joined Patient Power at the 2014 American Society of Hematology (ASH) meeting, to discuss developing research and treatment news. Dr. Greenwald discusses emerging approaches to treatment, including immunotherapy and targeted therapies and explains why he feels it is an "exciting time" for patients. Get...
by:patientpower | 54 views
11:15
Dr. Jeff Sharman, a leading CLL expert and Medical Director of Hematology Research at US Oncology Research, shares an overview of the ever-evolving CLL treatment landscape, including updates from the 2014 American Society of Hematology meeting. Get email alerts | http://www.p... Subscribe on YouTube | http://www.......
by:patientpower | 52 views
07:26
With many new and evolving myeloma treatments, how can patients ensure they are receiving the latest, state-of-the-ar​t care? Drs. John Burke and Robert Rifkin, Myeloma experts from US Oncology Research, explore important developments from the 2014 American Society of Hematology (ASH) meeting and explain how patients can work with their doctor to ac...
by:patientpower | 44 views
39:28
At the 2014 American Society of Hematology (ASH) meeting, Dr. Robert Orlowski from MD Anderson Cancer Center led a Patient Power roundtable discussion featuring Dr. Ola Landgren from Memorial Sloan Kettering Cancer Center, Dr. Edward Libby from Seattle Cancer Care Alliance and patient advocate and mentor Cynthia Chmielewski. The panel explored the ...
by:patientpower | 33 views
08:54
As part of our coverage of the 2014 American Society of Hematology (ASH) annual meeting, Dr. Claire Harrison joined Patient Power to discuss the latest news on JAK inhibitors for the treatment of MPNs. Dr. Harrison talked about recent FDA approval of ruxolitinib (Jakafi®) for the treatment of polycy...
by:patientpower | 70 views
12:31
http://cance... Immunotherapy Forum Video #3: In Part 1 of 2 videos on this topic, Dr. Matthew Hellmann from the Memorial Sloan Kettering Cancer Center discusses the century-long history of attempting to treat cancer with immunotherapy. GRACEcast 295 CA Rx
by:cancergrace | 53 views
04:06
A molecular-based approach in MPN studies, which has improved understanding of driver mutations, has rapidly increased recent advances in clinical management. Combinational therapies are in preliminary stages and focus is on the Janus kinase (JAK) inhibitor, ruxolitinib, in combinations that enhance...
by:EMJ | 62 views
05:19
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Denis-Claude Roy (University of Montreal, Montreal, Canada) discusses a phase II trial that evaluated selective photodepletion of recipient-allor​eactive T-cells (ATIR) for haploidentical haematopoietic stem cell transplant in patien...
by:EMJ | 85 views
04:55
During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Ruben Mesa from Mayo Clinic Arizona joined Patient Power to discuss the recent FDA approval of ruxolitinib (Jakafi®) for the treatment of polycythemia vera (PV)—the first medicine approved specifically to treat PV. Dr. Mesa exp...
by:patientpower | 72 views
04:35
During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Ajay Gopal from Seattle Cancer Care Alliance joined Patient Power to share exciting treatment news for lymphomas. He provided an overview of all the latest, including positive news about the oral therapy Zydelig® (idelalisib) i...
by:patientpower | 55 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)